Americas & Europe Tendinitis Market Overview
Tendinitis is that the inflammation of the tendon, thick cords that attache the muscles to the bone. The inflammation happens as a results of sudden injury to the tendon, repetitive movement or disease condition like polygenic disorder, reiter's syndrome, gout, Reiter's disease or lupus. just in case of patients with diabetes, the uric acid crystals within the gout tendon sheath resulting in friction. tendinitis is found to be prevalent among athletes and is one among the common sport injuries in sport players, especially court game, golf et al.. various pharmacologic and non-pharmacological treatments are offered for the treatment of tendinitis. Non-Steroidal anti-inflammatory medicine (NSAIDs) represent the preliminary treatment choices. alternative treatments as well as physical therapy, rest, and occupational therapy. Surgery is that the expedient for tendinitis, and is merely suggested just in case of severe damage to the sinew that can't be treated victimisation pharmacological treatment choices.
The market for tendinitis treatment is expected to grow at an exponential rate due to increasing prevalence of sports injuries, rising geriatric population, increasing prevalence of patients suffering from diabetes and rheumatoid arthritis. facet effects of the treatment i.e. use of NSAIDs resulting in stomach upset, and gastrointestinal (GI) bleeding.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Type, Treatment, End User, and Region |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Abbott Laboratories, Merck & Co. Inc., Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline plc., Pfizer Inc., Bayer, Teva Pharmaceutical Industries, AstraZeneca. |
The covid-19 Impact on Americas & Europe Tendinitis Market:
Like several different industries, COVID-19 badly knocked the electronic and semiconductor trade. This new event has compact nearly 230 countries in exactly a couple of weeks, leading to the forced conclusion of producing and transportation activities at intervals and across the countries. This has directly affected the expansion of the sector. It's calculable that COVID-19 to depart over USD thirty billion impacts on the physics and semiconductor trade. The arena is majorly affected thanks to transport restrictions on major physics and semiconductor staple suppliers. However, the rising want for semiconductors in many industries can supply fast market recovery over the longer-term amount.
Americas & Europe Tendinitis Market Segment Overview
By Type, On the basis of type, the market is segmented into Achilles tendinitis, supraspinatus tendinitis, lawn tennis or golfer's elbow, de Quervain's tenosynovitis, and others.
By Treatment, On the basis of treatment, the market is segmented into designation, therapy, shock wave therapy or surgery, medical devices, devices, and others.Diagnosis is further segmental into physical examination, imaging tests, ultrasound, magnetic resonance Imaging (MRI) Scans, and others.
On the basis of end user, the market is segmented into hospitals & clinics, medical analysis centers, academic institutes, and others.
Market Analysis, Insights and Forecast – By Type
· Achilles Tendinitis
· Supraspinatus Tendinitis
· Tennis or Golfers Elbow
· De Quervains Tenosynovitis
Market Analysis, Insights and Forecast – By Treatment
· Diagnosis Therapy
· Shock Wave Therapy or Surgery
· Medical Devices
· Devices
· Others.
Market Analysis, Insights and Forecast – By End User
· Hospitals & Clinics
· Medical Research Centers
· Academic Institutes
Americas & Europe Tendinitis Market Regional Overview
Region-wise, in terms of regions, American region is that the major market for tendonitis treatment attributable to rise in prevalence of sport injuries & malady like arthritis and increase in demand for new treatment choices for tendinitis within the region. European region is predicted to witness higher growth rate because of increase in accessibility of funds for research and development (R&D) activities in medical devices and rise in prevalence of diabetes & rheumatoid arthritis over the forecast amount.
Americas & Europe Tendinitis Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Americas & Europe Tendinitis Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Americas & Europe Tendinitis are highlighted below.
· In April 2018 – Samumed, LLC (US), a leader in Wnt analysis and development presented its latest preclinical and clinical data on the company’s investigational Wnt pathway inhibitors for the treatment of degenerative joint disease (SM04690) and tendinopathy (SM04755) at the 2018 osteoarthritis analysis Society International World Congress in urban center, U.K.
Americas & Europe Tendinitis Market, Key Players
· Abbott Laboratories
· Merck & Co. Inc.
· Boehringer Ingelheim Pharmaceuticals, Inc.
· GlaxoSmithKline plc.
· Pfizer Inc.
· Bayer
· Teva Pharmaceutical Industries
· AstraZeneca.
Frequently Asked Questions (FAQ) :
Q1. What is the total CAGR expected to be recorded for the Americas & Europe Tendinitis market during the forecast period?
Americas & Europe Tendinitis market is expected to record a CAGR of ~ 3.9 % during the forecast period.
Q2. Which segment is projected to hold the largest share in the Americas & Europe Tendinitis Market?
Hospital and Clinics segment is projected to hold the largest share in the Americas & Europe Tendinitis Market.
Q3. What are the driving factors for the Americas & Europe Tendinitis market?
The growing global geriatric population is liable to tendonitis or might be stricken by bone disorders, osteoporosis, rheumatoid arthritis, diabetes, and osteoarthritis. Constant innovation of technologies and therapies in treating rubor is causative to the expansion. confirmatory government initiatives and vital investments and collaborations amongst key players to expand product offerings are key factors that boost the growth of the Americas & Europe Tendinitis market progressively.
Q4. Which Segments are covered in the Americas & Europe Tendinitis market report?
Type, Treatment,End User, and Region, these segments are covered in the Americas & Europe Tendinitis market report
Q5. Which are the prominent players offering Americas & Europe Tendinitis?
Abbott Laboratories,Merck & Co. Inc.,Boehringer Ingelheim Pharmaceuticals, Inc.,GlaxoSmithKline plc.,Pfizer Inc.,Bayer,Teva Pharmaceutical Industries,AstraZeneca.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Americas & Europe Tendinitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Achilles Tendinitis
- 5.2.2. Supraspinatus Tendinitis
- 5.2.3. Tennis or Golfers Elbow
- 5.2.4. De Quervains Tenosynovitis
- 5.3. Market Analysis, Insights and Forecast – By Treatment
- 5.3.1. Diagnosis Therapy
- 5.3.2. Shock Wave Therapy or Surgery
- 5.3.3. Medical Devices
- 5.3.4. Devices
- 5.3.5. Others.
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Hospitals & Clinics
- 5.4.2. Medical Research Centers
- 5.4.3. Academic Institutes
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East, and Africa
6. North America Americas & Europe Tendinitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Achilles Tendinitis
- 6.2.2. Supraspinatus Tendinitis
- 6.2.3. Tennis or Golfers Elbow
- 6.2.4. De Quervains Tenosynovitis
- 6.3. Market Analysis, Insights and Forecast – By Treatment
- 6.3.1. Diagnosis Therapy
- 6.3.2. Shock Wave Therapy or Surgery
- 6.3.3. Medical Devices
- 6.3.4. Devices
- 6.3.5. Others.
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Hospitals & Clinics
- 6.4.2. Medical Research Centers
- 6.4.3. Academic Institutes
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Americas & Europe Tendinitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Achilles Tendinitis
- 7.2.2. Supraspinatus Tendinitis
- 7.2.3. Tennis or Golfers Elbow
- 7.2.4. De Quervains Tenosynovitis
- 7.3. Market Analysis, Insights and Forecast – By Treatment
- 7.3.1. Diagnosis Therapy
- 7.3.2. Shock Wave Therapy or Surgery
- 7.3.3. Medical Devices
- 7.3.4. Devices
- 7.3.5. Others.
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Hospitals & Clinics
- 7.4.2. Medical Research Centers
- 7.4.3. Academic Institutes
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Americas & Europe Tendinitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Achilles Tendinitis
- 8.2.2. Supraspinatus Tendinitis
- 8.2.3. Tennis or Golfers Elbow
- 8.2.4. De Quervains Tenosynovitis
- 8.3. Market Analysis, Insights and Forecast – By Treatment
- 8.3.1. Diagnosis Therapy
- 8.3.2. Shock Wave Therapy or Surgery
- 8.3.3. Medical Devices
- 8.3.4. Devices
- 8.3.5. Others.
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Hospitals & Clinics
- 8.4.2. Medical Research Centers
- 8.4.3. Academic Institutes
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East, and Africa Americas & Europe Tendinitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Achilles Tendinitis
- 9.2.2. Supraspinatus Tendinitis
- 9.2.3. Tennis or Golfers Elbow
- 9.2.4. De Quervains Tenosynovitis
- 9.3. Market Analysis, Insights and Forecast – By Treatment
- 9.3.1. Diagnosis Therapy
- 9.3.2. Shock Wave Therapy or Surgery
- 9.3.3. Medical Devices
- 9.3.4. Devices
- 9.3.5. Others.
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Hospitals & Clinics
- 9.4.2. Medical Research Centers
- 9.4.3. Academic Institutes
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. IBM Corporation
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Abbott Laboratories
- 10.6. Merck & Co. Inc.
- 10.7. Boehringer Ingelheim Pharmaceuticals, Inc.
- 10.8. GlaxoSmithKline plc.
- 10.9. Pfizer Inc.,
- 10.10. Bayer
- 10.11. Teva Pharmaceutical Industries
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
